The difference in gut microbiome between papillary thyroid cancer patients with and without coexistent hashimoto thyroiditis and its impact on the development of papillary thyroid cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300068130

Enrollment

Unknown

Registered

2023-02-08

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid carcinoma

Interventions

thyroid papillary carcinoma patients with Hashimoto's thyroiditis:No

thyroid papillary carcinoma patients without Hashimoto's thyroiditis:No

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with thyroid papillary carcinoma or Hashimoto's thyroiditis were diagnosed.

Exclusion criteria

Exclusion criteria: 1) Use probiotics, antibiotics, probiotics or symbiotic bacteria in the last three months. 2) Combined with other tumors.

Design outcomes

Primary

Measure	Time frame
Intestinal microbial detection;	—

Secondary

Measure	Time frame
Detection of intestinal metabolites;	—

Countries

China

Contacts

Public ContactYawen Tan

the Second People's Hospital of Shenzhen

tanyawen0630@163.com18575566630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026